CAR-T Cell Funding Market Size, Share, By Therapy Type (Tisagenlecleucel-T, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Lisocabtagene maraleucel, Idecabtagene vicleucel, and Ciltacabtagene autoleucel), By Investment Trend (Early-Stage investment, Late-Stage investment, and Strategic investment), By Funding Source Type (Venture Capital, Public Funding, Corporate Investments, and Others), By Application (Acute Lymphoblastic Leukemia (ALL), Ovarian Cancer, Acute Myeloid Leukemia (AML), Rheumatoid Arthritis (RA), and Others), By End-User (Pharmaceutical Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Outpatient Surgery Centers, and Others), and Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034